BioNexus Gene Lab Corp - Common stock — Cash Flow (NASDAQ:BGLC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 552.68 K9 161544.03 K-1.3 M-2.23 M-1.84 M -1.16 M Cash from investing activities 1.32 M-490.57 K-450.5 K-382.58 K418.2 K944.75 K 946.41 K Cash from financing activities -4 947-28.22 K115.96 K5.75 M144.97 K298.84 K 359.41 K Free cash flow 552.68 K9 161544.03 K-1.3 M-2.23 M-1.84 M -1.16 M

News

BioNexus Gene Lab appoints commercial officer at Fidelion

BioNexus Gene Lab completes strategic deal with Fidelion Diagnostics

BioNexus Gene Lab stock falls after securing $500M equity facility

BioNexus Gene Lab secures $500 million equity purchase agreement

BioNexus Gene Lab stock climbs after securing $500 million equity facility

BioNexus Gene Lab forms partnership to commercialize liquid biopsy platform

BioNexus Gene Lab stock soars after strategic MRD testing agreements

BioNexus Gene Lab files $100 million shelf registration, launches ATM program

BioNexus Gene Lab enters strategic partnership talks with BirchBioMed

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.38%

US Stocks Edge Higher; Kraft Heinz Earnings Top Views - BioNexus Gene Lab (NASDAQ:BGLC), Kraft Heinz (NASDAQ:KHC)

Why Interactive Brokers Group Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket - BioNexus Gene Lab (NASDAQ:BGLC), 180 Life Sciences (NASDAQ:ATNF)